{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:59:32Z","timestamp":1790254772601,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220530145006013"],"award-info":[{"award-number":["JCYJ20220530145006013"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20240813150415021"],"award-info":[{"award-number":["JCYJ20240813150415021"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32300757"],"award-info":[{"award-number":["32300757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Medical Research Fund","award":["A2303022"],"award-info":[{"award-number":["A2303022"]}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010598"],"award-info":[{"award-number":["2024A1515010598"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04479-9","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:37:49Z","timestamp":1783064269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NKG2A\u2013HLA-E and TIM3\u2013galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancreatic ductal adenocarcinoma"],"prefix":"10.1007","volume":"75","author":[{"given":"Yuanyu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanhua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxiang","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0108-2103","authenticated-orcid":false,"given":"Guoying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"4","key":"4479_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","volume":"16","author":"EA Collisson","year":"2019","unstructured":"Collisson EA, Bailey P, Chang DK, Biankin AV (2019) Molecular subtypes of pancreatic cancer. Nat Rev Gastro Hepat 16(4):207\u2013220. https:\/\/doi.org\/10.1038\/s41575-019-0109-y","journal-title":"Nat Rev Gastro Hepat"},{"issue":"1","key":"4479_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000073222","volume":"68","author":"O Strobel","year":"2003","unstructured":"Strobel O, Z\u2019Graggen K, Schmitz-Winnenthal FH, Friess H, Kappeler A, Zimmermann A, Uhl W, Buchler MW (2003) Risk of malignancy in serous cystic neoplasms of the pancreas. Digestion 68(1):24\u201333. https:\/\/doi.org\/10.1159\/000073222","journal-title":"Digestion"},{"issue":"38","key":"4479_CR3","doi-asserted-by":"publisher","first-page":"13833","DOI":"10.3748\/wjg.v20.i38.13833","volume":"20","author":"I Esposito","year":"2014","unstructured":"Esposito I, Konukiewitz B, Schlitter AM, Kloppel G (2014) Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments. World J Gastroentero 20(38):13833\u201313841. https:\/\/doi.org\/10.3748\/wjg.v20.i38.13833","journal-title":"World J Gastroentero"},{"key":"4479_CR4","doi-asserted-by":"publisher","first-page":"188851","DOI":"10.1016\/j.bbcan.2022.188851","volume":"1","author":"P Raut","year":"1878","unstructured":"Raut P, Nimmakayala RK, Batra SK (1878) Ponnusamy MP (2023) Clinical and molecular attributes and evaluation of pancreatic cystic neoplasm. BBA-Rev Cancer 1:188851. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188851","journal-title":"BBA-Rev Cancer"},{"issue":"1061","key":"4479_CR5","doi-asserted-by":"publisher","first-page":"20150853","DOI":"10.1259\/bjr.20150853","volume":"89","author":"A Strauss","year":"2016","unstructured":"Strauss A, Birdsey M, Fritz S, Schwarz-Bundy BD, Bergmann F, Hackert T, Kauczor H, Grenacher L, Klauss M (2016) Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines. Brit J Radiol 89(1061):20150853. https:\/\/doi.org\/10.1259\/bjr.20150853","journal-title":"Brit J Radiol"},{"issue":"7","key":"4479_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.6004\/jnccn.2023.0034","volume":"21","author":"EG Chiorean","year":"2023","unstructured":"Chiorean EG, Chiaro MD, Tempero MA, Malafa MP, Benson AB, Cardin DB, Christensen JA, Chung V, Czito B, Dillhoff M, Donahue TR, Dotan E, Fountzilas C, Glazer ES, Hardacre J, Hawkins WG, Klute K, Ko AH, Kunstman JW, LoConte N, Lowy AM, Masood A, Moravek C, Nakakura EK, Narang AK, Nardo L, Obando J, Polanco PM, Reddy S, Reyngold M, Scaife C, Shen J, Truty MJ, Vollmer C, Wolff RA, Wolpin BM, Rn BM, Lubin S, Darlow SD (2023) Ampullary adenocarcinoma, Version 1.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Ne 21(7):753\u2013782. https:\/\/doi.org\/10.6004\/jnccn.2023.0034","journal-title":"J Natl Compr Canc Ne"},{"issue":"3","key":"4479_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/MOG.0b013e3283378eb0","volume":"26","author":"S Heinrich","year":"2010","unstructured":"Heinrich S, Clavien P (2010) Ampullary cancer. Curr Opin Gastroen 26(3):280\u2013285. https:\/\/doi.org\/10.1097\/MOG.0b013e3283378eb0","journal-title":"Curr Opin Gastroen"},{"issue":"1","key":"4479_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12967-022-03473-w","volume":"20","author":"J Cheng","year":"2022","unstructured":"Cheng J, Mao Y, Hong W, Hu W, Shu P, Huang K, Yu J, Jiang M, Li L, Wang W, Ni D, Li S (2022) Multimodal data analysis reveals that pancreatobiliary-type ampullary adenocarcinoma resembles pancreatic adenocarcinoma and differs from cholangiocarcinoma. J Transl Med 20(1):272. https:\/\/doi.org\/10.1186\/s12967-022-03473-w","journal-title":"J Transl Med"},{"issue":"7","key":"4479_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP (2021) Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastro Hepat 18(7):493\u2013502. https:\/\/doi.org\/10.1038\/s41575-021-00457-x","journal-title":"Nat Rev Gastro Hepat"},{"issue":"12","key":"4479_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41571-020-0413-z","volume":"17","author":"L Galluzzi","year":"2020","unstructured":"Galluzzi L, Humeau J, Buque A, Zitvogel L, Kroemer G (2020) Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nat Rev Clin Oncol 17(12):725\u2013741. https:\/\/doi.org\/10.1038\/s41571-020-0413-z","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"4479_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.trecan.2018.04.001","volume":"4","author":"AH Morrison","year":"2018","unstructured":"Morrison AH, Byrne KT, Vonderheide RH (2018) Immunotherapy and Prevention of Pancreatic Cancer. Trends Cancer 4(6):418\u2013428. https:\/\/doi.org\/10.1016\/j.trecan.2018.04.001","journal-title":"Trends Cancer"},{"issue":"8","key":"4479_CR12","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1111\/cas.14514","volume":"111","author":"N Hiraoka","year":"2020","unstructured":"Hiraoka N, Ino Y, Hori S, Yamazaki-Itoh R, Naito C, Shimasaki M, Esaki M, Nara S, Kishi Y, Shimada K, Nakamura N, Torigoe T, Heike Y (2020) Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients. Cancer Sci 111(8):3057\u20133070. https:\/\/doi.org\/10.1111\/cas.14514","journal-title":"Cancer Sci"},{"issue":"2","key":"4479_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","volume":"41","author":"X Liu","year":"2023","unstructured":"Liu X, Song J, Zhang H, Liu X, Zuo F, Zhao Y, Zhao Y, Yin X, Guo X, Wu X, Zhang H, Xu J, Hu J, Jing J, Ma X, Shi H (2023) Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. Cancer Cell 41(2):272\u2013287. https:\/\/doi.org\/10.1016\/j.ccell.2023.01.001","journal-title":"Cancer Cell"},{"key":"4479_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003213","author":"Q Meng","year":"2021","unstructured":"Meng Q, Xie S, Gray GK, Dezfulian MH, Li W, Huang L, Akshinthala D, Ferrer E, Conahan C, Perea Del Pino S, Grossman J, Elledge SJ, Hidalgo M, Muthuswamy SK (2021) Empirical identification and validation of tumor-targeting T cell receptors from circulation using autologous pancreatic tumor organoids. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-003213","journal-title":"J Immunother Cancer"},{"issue":"1","key":"4479_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-023-01499-1","volume":"16","author":"L Cai","year":"2023","unstructured":"Cai L, Li Y, Tan J, Xu L, Li Y (2023) Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy. J Hematol Oncol 16(1):101. https:\/\/doi.org\/10.1186\/s13045-023-01499-1","journal-title":"J Hematol Oncol"},{"issue":"3","key":"4479_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2217\/imt-2021-0075","volume":"15","author":"E Li","year":"2023","unstructured":"Li E, Xu J, Chen Q, Zhang X, Xu X, Liang T (2023) Galectin-9 and PD-L1 antibody blockade combination therapy inhibits tumour progression in pancreatic cancer. Immunotherapy-UK 15(3):135\u2013147. https:\/\/doi.org\/10.2217\/imt-2021-0075","journal-title":"Immunotherapy-UK"},{"issue":"1","key":"4479_CR17","doi-asserted-by":"publisher","first-page":"e6844","DOI":"10.1002\/cam4.6844","volume":"13","author":"J Lim","year":"2024","unstructured":"Lim J, Kurzrock R, Nishizaki D, Miyashita H, Adashek JJ, Lee S, Pabla S, Nesline M, Conroy JM, DePietro P, Lippman SM, Kato S (2024) Pan-cancer analysis of TIM-3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity. Cancer Med-US 13(1):e6844. https:\/\/doi.org\/10.1002\/cam4.6844","journal-title":"Cancer Med-US"},{"issue":"10","key":"4479_CR18","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.ccell.2021.07.007","volume":"39","author":"WA Freed-Pastor","year":"2021","unstructured":"Freed-Pastor WA, Lambert LJ, Ely ZA, Pattada NB, Bhutkar A, Eng G, Mercer KL, Garcia AP, Lin L, Rideout WMR, Hwang WL, Schenkel JM, Jaeger AM, Bronson RT, Westcott PMK, Hether TD, Divakar P, Reeves JW, Deshpande V, Delorey T, Phillips D, Yilmaz OH, Regev A, Jacks T (2021) The CD155\/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer. Cancer Cell 39(10):1342\u20131360. https:\/\/doi.org\/10.1016\/j.ccell.2021.07.007","journal-title":"Cancer Cell"},{"issue":"14","key":"4479_CR19","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1158\/1078-0432.CCR-23-0258","volume":"29","author":"M Heiduk","year":"2023","unstructured":"Heiduk M, Klimova A, Reiche C, Digomann D, Beer C, Aust DE, Distler M, Weitz J, Seifert AM, Seifert L (2023) TIGIT expression delineates T-cell populations with distinct functional and prognostic impact in pancreatic cancer. Clin Cancer Res 29(14):2638\u20132650. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0258","journal-title":"Clin Cancer Res"},{"key":"4479_CR20","doi-asserted-by":"publisher","first-page":"1267279","DOI":"10.3389\/fimmu.2023.1267279","volume":"14","author":"A Quilbe","year":"2023","unstructured":"Quilbe A, Mustapha R, Duchene B, Kumar A, Werkmeister E, Leteurtre E, Morales O, Jonckheere N, Van Seuningen I, Delhem N (2023) A novel anti-galectin-9 immunotherapy limits the early progression of pancreatic neoplastic lesions in transgenic mice. Front Immunol 14:1267279. https:\/\/doi.org\/10.3389\/fimmu.2023.1267279","journal-title":"Front Immunol"},{"issue":"7","key":"4479_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez J, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9(7):676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019","journal-title":"Nat Methods"},{"issue":"W1","key":"4479_CR22","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z (2019) GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 47(W1):W556\u2013W560. https:\/\/doi.org\/10.1093\/nar\/gkz430","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"4479_CR23","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48(W1):W509\u2013W514. https:\/\/doi.org\/10.1093\/nar\/gkaa407","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"4479_CR24","doi-asserted-by":"publisher","first-page":"W534","DOI":"10.1093\/nar\/gkaf388","volume":"53","author":"H Cui","year":"2025","unstructured":"Cui H, Zhao G, Lu Y, Zuo S, Duan D, Luo X, Zhao H, Li J, Zeng Z, Chen Q, Li T (2025) TIMER3: an enhanced resource for tumor immune analysis. Nucleic Acids Res 53(W1):W534\u2013W541. https:\/\/doi.org\/10.1093\/nar\/gkaf388","journal-title":"Nucleic Acids Res"},{"issue":"722","key":"4479_CR25","doi-asserted-by":"publisher","first-page":"eadh9562","DOI":"10.1126\/scitranslmed.adh9562","volume":"15","author":"Z Meng","year":"2023","unstructured":"Meng Z, Rodriguez Ehrenfried A, Tan CL, Steffens LK, Kehm H, Zens S, Lauenstein C, Paul A, Schwab M, F\u00f6rster JD, Salek M, Riemer AB, Wu H, Eckert C, Leonhardt C, Strobel O, Volkmar M, Poschke I, Offringa R (2023) Transcriptome-based identification of tumor-reactive and bystander CD8(+) T cell receptor clonotypes in human pancreatic cancer. Sci Transl Med 15(722):eadh9562. https:\/\/doi.org\/10.1126\/scitranslmed.adh9562","journal-title":"Sci Transl Med"},{"issue":"D1","key":"4479_CR26","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, Wu J, Tang H, Zheng S, Liu Y, Wu Y, Luo X, Xie Y, Ren J (2025) Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res 53(D1):D1670\u2013D1676. https:\/\/doi.org\/10.1093\/nar\/gkae973","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4479_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41392-025-02228-5","volume":"10","author":"J Xie","year":"2025","unstructured":"Xie J, Liu X, Zhou T, Liu L, Hou R, Yu X, Fan Z, Shang Q, Chang Y, Zhao X, Wang Y, Xu L, Zhang X, Huang X, Zhao X (2025) Overexpressing natural killer group 2 member A drives natural killer cell exhaustion in relapsed acute myeloid leukemia. Signal Transduct Tar 10(1):143. https:\/\/doi.org\/10.1038\/s41392-025-02228-5","journal-title":"Signal Transduct Tar"},{"issue":"1","key":"4479_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","volume":"18","author":"X Jiang","year":"2019","unstructured":"Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B, Wu X, Ma J, Zhou M, Li X, Li Y, Li G, Xiong W, Guo C, Zeng Z (2019) Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape. Mol Cancer 18(1):10. https:\/\/doi.org\/10.1186\/s12943-018-0928-4","journal-title":"Mol Cancer"},{"issue":"6","key":"4479_CR29","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/s41423-020-00575-7","volume":"18","author":"Y Zhai","year":"2021","unstructured":"Zhai Y, Celis-Gutierrez J, Voisinne G, Mori D, Girard L, Burlet-Schiltz O, de Peredo AG, Roncagalli R, Malissen B (2021) Opposing regulatory functions of the TIM3 (HAVCR2) signalosome in primary effector T cells as revealed by quantitative interactomics. Cell Mol Immunol 18(6):1581\u20131583. https:\/\/doi.org\/10.1038\/s41423-020-00575-7","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"4479_CR30","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1158\/2326-6066.CIR-16-0322","volume":"5","author":"IM Stromnes","year":"2017","unstructured":"Stromnes IM, Hulbert A, Pierce RH, Greenberg PD, Hingorani SR (2017) T-cell localization, activation, and clonal expansion in human pancreatic ductal adenocarcinoma. Cancer Immunol Res 5(11):978\u2013991. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0322","journal-title":"Cancer Immunol Res"},{"issue":"13","key":"4479_CR31","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.7150\/thno.86547","volume":"13","author":"H Ma","year":"2023","unstructured":"Ma H, Chen X, Mo S, Mao X, Chen J, Liu Y, Lu Z, Yu S, Chen J (2023) The spatial coexistence of TIGIT\/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma. Theranostics 13(13):4601\u20134614. https:\/\/doi.org\/10.7150\/thno.86547","journal-title":"Theranostics"},{"issue":"12","key":"4479_CR32","doi-asserted-by":"publisher","first-page":"113516","DOI":"10.1016\/j.celrep.2023.113516","volume":"42","author":"J Middelburg","year":"2023","unstructured":"Middelburg J, Ghaffari S, Schoufour TAW, Sluijter M, Schaap G, Goynuk B, Sala BM, Al-Tamimi L, Scheeren F, Franken KLMC, Akkermans JJLL, Cabukusta B, Joosten SA, Derksen I, Neefjes J, van der Burg SH, Achour A, Wijdeven RHM, Weidanz J, van Hall T (2023) The MHC-E peptide ligands for checkpoint CD94\/NKG2A are governed by inflammatory signals, whereas LILRB1\/2 receptors are peptide indifferent. Cell Rep 42(12):113516. https:\/\/doi.org\/10.1016\/j.celrep.2023.113516","journal-title":"Cell Rep"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04479-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04479-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04479-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:02:54Z","timestamp":1790251374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04479-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["4479"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04479-9","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with 1964 Declaration of Helsinki\u00a0and its later amendments\u00a0and approved by the local medical ethics committee (KY-2023-120-01, KY-2025-379-01 and KY-2026-198-01) of the Seventh Affiliated Hospital of Sun Yat-sen University, and informed consent\u00a0from all patients was obtained before tissue and blood donation.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"234"}}